ERS Assembly 13: Pulmonary vascular diseases

Group 13.01
Chair: Silvia Ulrich
Secretary: Adir Yochai

Group 13.02
Chair: Laurent Bertoletti
Secretary: Luis Jose Jara-Palomares

Pulmonary embolism (PE) is the third leading cause of cardiovascular death, after acute myocardial infarction and stroke.

Our Group is dedicated to the diagnosis, risk stratification, treatment of the acute phase of PE and follow-up. Our objectives are focused on training and research, identifying areas of interest to improve the care of our patients. In the acute situation of the thrombotic event, it is crucial to carry out an adequate risk stratification to adapt the care to the patient's risk of suffering complications. In the follow-up of the patient with PE, the risk of recurrence, the risk of bleeding, as well as other factors and variables to be considered (search for occult neoplasia, identification of other cardiovascular risk factors, identify the profile of patients who benefit from thrombophilia testing, sports activities after the thrombotic event, etc.). This Group is dynamic and wants to incorporate anyone who is interested in any of the facets of this disease (acute or follow-up), and from the point of view of training or research.

Joining our Group provides a direct connection to clinicians, academics and researchers working in this field.